Delicious
Digg
Facebook
LinkedIn
Twitter
DUBLIN, Calif., Jun 02, 2010 (BUSINESS WIRE) --SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the Jefferies Global Life Sciences Conference on June 8th at 8 am in New York. In addition, Mohammad Azab., M.D., Chief Medical Officer, will present at the Needham Healthcare Conference on Wednesday, June 9th at 8 am in New York.
A live webcast of the Jefferies presentation will be available in the Investor Events section of the Company's Web site at www.supergen.com. The webcast will be archived for 30 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.
SOURCE: SuperGen, Inc.
Timothy L. Enns
SuperGen, Inc.
Senior Vice President
Corporate Communications & Business Development
Tel: (925) 560-2810
E-mail: tenns@supergen.com
or
Susanna Chau
SuperGen, Inc.
Manager
Investor Relations
Tel: (925) 560-2845
E-mail: schau@supergen.com
Mixx
Yahoo! Buzz